FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOptimi Health Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OPTH
Optimi Health Corp. Stock AnalysisComprehensive stock analysis for Optimi Health Corp. (OPTH) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOPTH
OPTH
Optimi Health Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OPTH
  1. Home
  2. Stocks
  3. Optimi Health Corp.

Optimi Health Corp.

🇺🇸OPTH•NASDAQ

Optimi Health Corp.

🇺🇸OPTH•NASDAQ
Market cap
$8.65M

Your view on OPTH

Mkt Cap
$8.65M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Optimi Health Corp.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Dane Stevens
Headquarters
269 David Brown Way, Princeton, BC, CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Dane Stevens
Headquarters
269 David Brown Way, Princeton, BC, CA
Description

Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products.

The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners.

Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market.

Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Optimi Health Corp.. Starting points for Optimi Health Corp.: EPS -$1.61, beta 1.48 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Optimi Health Corp.. Trailing twelve-month EPS for Optimi Health Corp. stands at -$1.61. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Optimi Health Corp.. Optimi Health Corp. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OPTH12 companies
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
KOANResonate Blends, Inc.HealthcareOTC$351,448
KSPHFKissei Pharmaceutical Co., Ltd.HealthcareOTC$1.1B
LABFFLaboratorios Farmaceuticos Rovi, S.A.HealthcareOTC$4.6B
LABS.TOMediPharm Labs Corp.HealthcareTSX$25.6M
LEEEFLeef Brands Inc.HealthcareOTC$25.6M
LEEF.CNLeef Brands Inc.HealthcareCNQ$38.1M
LFCRLifecore Biomedical, Inc.HealthcareNASDAQ$242.2M
LGP.AXLittle Green Pharma LtdHealthcareASX—
LITHBioELife Corp.HealthcareOTC—
LMLLFPharmadrug Inc.HealthcareOTC$746,817
LNTHLantheus Holdings, Inc.HealthcareNASDAQ$6.7B
LOVE.TOCannara Biotech Inc.HealthcareTSX$198.6M
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Optimi Health Corp.. Coverage tracks Optimi Health Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Optimi Health Corp.

OPTH AnalysisFair
Past
1
Growth
5
Health
4
Profit
1
Value
1